Innoviva (NASDAQ: INVA) reported Q1 EPS of $0.19, $0.07 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $40.5 million versus the consensus estimate of $47.06 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.